BiosensorsProgress in Optical Methods for the Detection of Two Core Blood Biomarkers of Alzheimer's Disease: Amyloid-Beta and Tau ProteinsBy Ning Xia, Fengli Gao, Chuye ZhengOpen the figure at full sizeFigure 1. Schematic illustration of synthesis of AptDzNz-Sens (a) and colorimetric urinalysis of AD (b).Schematic illustration of synthesis of AptDzNz-Sens (a) and colorimetric urinalysis of AD (b).Xia et al.ReviewBiomarkersPaperAlzheimer's diseaseAmyloid-betaAPPTauMAPTHumansThe paperNing Xia, Fengli Gao, Chuye ZhengAnyang Normal UniversityBiosensors, 6 Aug 2026doi.org/10.3390/bios16080427PubMed 42645045
bioRxiv·2 Oct 2026Directly converted human neuronal spheroids preserve donor age and model Alzheimer disease